By proceeding, you agree to our Terms of Use and Privacy Policy.
The Medtech & Pharma Platform 2022 Annual Conference (MPP 2022) will take place on 8 September 2022 in Basel. The Annual Conference endeavours to foster cross-sectoral exchange and synergies between the pharma, medtech and tech industries.
Notified bodies from Pharma and Medtech will share forward looking perspectives on the regulation of combined products along with lessons learned.
Industry experts from Novartis, US FDA and Swissmedic will discuss regulatory framework for combined products & how to go from research to development.
Essential networking sessions will advance your partnerships in the Pharma sector to promote digital health for bringing significant benefits to the fore.
The MPP Association aims to enhance interactions between pharma, medtech and tech industries, in order to promote product development and innovation.
Very helpful interaction with other experts in the field.
Event was helpful and good insights in some new areas.
Capgemini is a global leader in partnering with companies to transform and manage their business by harnessing the power of technology.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
SFL is a leading consultancy providing integrated solutions to pharma, biotech and medtech companies for all product life cycle stages: Regulatory Affairs & Regulatory Intelligence, Quality & Supply Chain, Medical Writing, Public Affairs & Market Acc
The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 35 years’ experience.
Novartis is reimagining medicine to improve and extend people s lives As a leading global medicines company we use innovative science and digital technologies to create transformative treatments in areas of great medical need In our quest to find new
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.